Buy, Sell or Hold JAZZ Stock? Key Tips Ahead of Q1 Earnings

  • Investors will likely focus on the sales performance of Jazz Pharmaceuticals' key neuroscience drugs, Xywav and Rylaze, when it reports Q1 results next week.